tiprankstipranks
Advertisement
Advertisement

WELL Health Posts Record 2025 Results and Sets Ambitious 2026 Growth Targets

Story Highlights
  • WELL Health delivered record 2025 revenue and EBITDA, driven by acquisitions, organic growth, and strong Canadian patient services performance.
  • The company issued upbeat 2026 guidance and plans a WELLSTAR spin-out, while prioritizing higher-margin Canadian primary care and diagnostics expansion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
WELL Health Posts Record 2025 Results and Sets Ambitious 2026 Growth Targets

Claim 55% Off TipRanks

An update from WELL Health Technologies Corp ( (TSE:WELL) ) is now available.

WELL Health Technologies reported record 2025 results, with revenue surging 52% to $1.40 billion and Adjusted EBITDA climbing to $203.7 million, supported by acquisitions, organic growth and the consolidation of HEALWELL. Canadian Patient Services delivered 39% revenue growth and 43% Adjusted EBITDA growth, while operating free cash flow attributable to shareholders rose 19%, underpinned by an expanded credit facility and disciplined execution of 19 clinic acquisitions.

The company signaled confidence in its outlook for 2026, guiding to $1.55–$1.65 billion in revenue and $175–$185 million in Adjusted EBITDA, and targeting at least 10% annual normalized Adjusted EBITDA and free cash flow growth, excluding certain U.S. deferrals. Management highlighted WELLSTAR’s increasingly AI-enabled platform and a planned spin-out intended to unlock its embedded value, while emphasizing a continued focus on higher-margin Canadian primary care and diagnostics assets to reinforce its role as infrastructure for a healthier Canada.

The most recent analyst rating on (TSE:WELL) stock is a Buy with a C$9.00 price target. To see the full list of analyst forecasts on WELL Health Technologies Corp stock, see the TSE:WELL Stock Forecast page.

Spark’s Take on WELL Stock

According to Spark, TipRanks’ AI Analyst, WELL is a Neutral.

WELL Health Technologies Corp’s overall stock score is driven by strong revenue growth and positive earnings call sentiment. However, significant challenges in profitability, cash flow management, and technical indicators weigh down the score. The negative P/E ratio and lack of dividend yield further impact the valuation negatively.

To see Spark’s full report on WELL stock, click here.

More about WELL Health Technologies Corp

WELL Health Technologies Corp. is a Vancouver-based digital healthcare company that operates clinics and technology platforms aimed at improving health outcomes in Canada and globally. Its portfolio includes physical care clinics, the WELLSTAR digital workflow platform, HEALWELL’s AI-driven healthcare capabilities, and CyberWELL’s data protection services, with a strategic focus on Canadian primary care and diagnostics alongside a U.S. portfolio.

Average Trading Volume: 1,344,166

Technical Sentiment Signal: Sell

Current Market Cap: C$1.08B

For detailed information about WELL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1